Clinical Trials Directory

Trials / Completed

CompletedNCT06632548

Retention of Three Different Types of Telescopic Attachments

Retention of Three Different Secondary Copings in Telescopic Attchments Used to Stabilize Implant Retained Mandibular Overdenture a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Moatz Aly Ahmed Hussien · Academic / Other
Sex
All
Age
55 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study was conducted on thirty patients. These patients were divided into three groups in a random manner to compare the retention forces between three different types of secondary crowns used to stabilize two implant mandibular overdentures. in all groups the primary coping was fabricated from milled titanium while the secondary coping was milled titanium in first group ,3D printed cobalt chromium in the second group and milled poly ether ketone ketone in the third group the retention forces was measured using forcemeter immediately after insertion and after 3,6, months

Detailed description

A thirty edentulous patients Was selected from outpatient clinic of Exclusion criteria: 1. systemic and metabolic disorders that may complicate osseointegration. 2. Patients receiving bisphosphonates. 3. patients receiving radiotherapy. The patients was assigned into three groups using balanced randomly. Patients was randomly allocated into one of three groups using random numbers generated using Excel program. Group I included patients who received 2 implants and telescopic overdentures with milled titanium primary and secondary coping Group II included patients who received telescopic overdentures with milled titanium primary coping and three dimensionally printed secondary coping GroupIII patients recived milled titanium primary coping and poly ether ketone ketone secondary copings (PEKK) secondary coping All patients signed an informed consent. Surgical and prosthetic protocols: A radiographic stent with gutta percha markers at the canine region was fabricated and the patient was instructed to wear it during cone beam radiographic evaluation to evaluate proposed implant sites regarding bone height and thickness, and approximation to vital structures (mental foramen). Radiographic template was converted to surgical template. The two implants was inserted nearly parallel as possible. If inclination of the implants was inevitable buccally or lingually due to mandibular concavities, the inclination was compensated later during design of primary copings. The implants was inserted in the canine region with two steps surgical protocol. After three months of the insertion and osseointegration implants was exposed and healing abutments was inserted after gingival healing implant level impression will be taken. The metallic primary coping was milled with 2-degree convergence for all cases while the second coping was milled titanium or 3D printed cobalt chromium or milled PEKK according the patient group. the primary copings was screwed to the implants and the secondary coping pick up was done and patient was instructed to follow oral hygiene measures and was scheduled for periodic follow up every 3 months. Evaluation of overdenture retention: Force meter device was used to measure the retention of the mandibular overdenture in Newton. The patient was seated on upright position and asked to open his mouth until the occlusal surface of the lower denture is parallel to the floor and the maximum dislodging force to remove the denture is recorded using digital forcemeter. Measurement of retention forces was made immediately after overdenture insertion and repeated at 3,6,9and 12 months after insertion after by independent dental personnel blinded to treatment groups.

Conditions

Interventions

TypeNameDescription
DEVICEtelescopic overdenturetwo implant retained mandibular overdenture with telescopic attachment

Timeline

Start date
2022-08-30
Primary completion
2024-01-30
Completion
2024-03-30
First posted
2024-10-09
Last updated
2024-10-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06632548. Inclusion in this directory is not an endorsement.